Development and Optimization of Macroparticles of Rifaximin for Colon Targeting
DOI:
https://doi.org/10.37285/ijpsn-aktu.2022-22Abstract
Objectives: This study is focused to design a colon specific pellet formulation based on the combined use of time-dependent and pH sensitive delivery system using Quality-by-Design (QbD) approach for better and promising treatment of inflammatory bowel disease (IBD).
Materials and Methods: An extrusion-spheronization process was utilized for production of core pellets using ethyl cellulose (EC) as matrix former and microcrystalline cellulose (MCC) as a spheronizing aid. Two critical process parameters (CPPs) i.e., spheronization time and spheronizer speed were taken as independent factors while aspect ratio, sphericity, carr's index, and particle size were taken as dependent responses to optimize the composition of the core pellets. To regulate the drug release, core pellets were coated with Eudragit NE40D and Eudragit FS30D to impart time-dependent and pH sensitive release of drug.
Results: The optimized coated pellets were characterized for concentration of drug and release of drug from the formulation in vitro in different pH media of stomach and intestine. The coating level of the inner and outer polymers was further optimized for the time required for 10 %, 50 % and 90 % drug release. The invitro release profile of the coated pellets depicted the prolonged release of rifaximin. When exposed to Scanning Electron Microscopy the images of coated pellets suggested a uniform and smooth coat of polymers over the surface of pellets.
Conclusion: The formulation in this research work is intended for specific targeting of drug to treat inflammation and owing to this the dose and the associated side effect reduces. This is how it may be better option in comparison to tablets. The result indicates that the developed formulation may possibly reduce the dosing frequency and side effects associated with the conventional tablet formulation for the site-specific targeting at inflammation site.
Downloads
Metrics
Keywords:
Pellets, colon targeted, Eudragit, MCC, OptimizationPublished
How to Cite
Issue
Section
References
Sinha VR, Mittal BR, Bhutani KK, Kumria R. Colonic drug delivery of 5-fluorouracil: an in vitro evaluation. Int J Pharm 2004; 269: 101-8.
Orlu M, Cevher E, Araman A. Design and evaluation of colon specific drug delivery system containing flurbiprofen microsponges. Int J Pharm 2006; 318: 103-117.
Zhang F. Melt-extruded Eudragit® FS-based granules for colonic drug delivery. AAPS PharmSciTech 2016; 17: 56-67.
Wei H, Qing D, De-Ying C, Bai X, Li-Fang F. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm 2008; 348: 35-45.
Gupta VK, Beckert TE, Price JC. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm 2001;213:83-91.
Akhgari A, Sadeghi F, Garekani HA. Combination of timedependent and pH-dependent polymethacrylates as a single coating formulation for colonic delivery of indomethacin pellets. Int J Pharm. 2006; 320(1):137-42.
Jatinder Kumar and AMJ Newton, Colon Targeted Rifaximin Nanosuspension for the Treatment of Inflammatory Bowel Disease (IBD). Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry, 2016, 15, 1-17.
He W, Du Q, Cao DY, Xiang B, Fan LF. Study on colon-specific pectin/ethylcellulose film-coated 5-fluorouracil pellets in rats. Int J Pharm. 2008;348(1):35-45.
Steckel H, Mindermann-Nogly F. Production of chitosan pellets by extrusion/spheronization. Eur J Pharm Biopharm. 2004;57(1):107-14.
Sriamornsak P, Nunthanid J, Luangtana-Anan M, Weerapol Y, Puttipipatkhachorn S. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts. Eur J Pharm Biopharm. 2008;69(1):274-84.
Del Curto MD, Palugan L, Foppoli A, et al. Erodible time-dependent colon delivery systems with improved efficiency in delaying the onset of drug release. J Pharm Sci 2014;103:3585-3593.
Maroni A, Del Curto MD, Cerea M, et al. Polymeric coatings for a multiple-unit pulsatile delivery system: Preliminary study on free and applied films. Int J Pharm 2013;440:256-63.
Liu F, Moreno P, Basit AW. A novel double-coating approach for improved pH triggered delivery to the ileo-colonic region of the gastrointestinal tract. Eur J Pharm Biopharm 2010;74:311-15.
Akhgari A, Garekani HA, Sadeghi F, Azimaie M. Statistical optimization of indomethacin pellets coated with pH-dependent methacrylic polymers for possible colonic drug delivery. Int J Pharm 2005;305:22-30.
Sadeghi F., Ford, J. L., Rubinstein, M. H. & Rajabi-Siahboomi, A. R. 2000. Comparative study of drug release from pellets coated with HPMC or Surelease. Drug development and industrial pharmacy, 26, 651-660.
Wairkar S.M., Gaud, R.S., 2016. Formulation and IN-vitro characterisation OF sustained Release matrix pellets OF nateglinide. Int. J. Pharm. Sci. Res. 7 (7), 2925.
Zhao H., Sun, D., Tang, Y., Yao, J., Yuan, X., Zhang, M., 2018. Thermo/pH dualresponsive core–shell particles for apatinib/doxorubicin controlled release: preparation, characterization and biodistribution. J. Mater. Chem. B 6 (46), 7621–7633.
Kulthe SS, Bahekar JK, Godhani CC, et al. Modulated release of 5-fluorouracil from pH-sensitive and colon targeted pellets: An industrially feasible approach. Drug Dev Ind Pharm 2013;39:138–45.
Beckert TE, Gupta VK, Price JC. A novel pH- and time-based multi-unit potential colonic drug delivery system. I. Development. Int J Pharm 2001;213:83-91.
Liu F, Moreno P, Basit AW. A novel double-coating approach for improved pH triggered delivery to the ileo-colonic region of the gastrointestinal tract. Eur J Pharm Biopharm 2010;74:311-15.
Paharia A., Yadav, A. K., Rai, G., Jain, S. K., Pancholi, S. S. & Agrawal, G. P. 2007. Eudragit-coated pectin microspheres of 5-fluorouracil for colon targeting. Aaps Pharmscitech, 8, E87-E93.
Baert L. and Remon, J.P., Influence of amount of granulation liquid on the drug release rate from pellets made by extrusion-spheronisation. Int. J. Pharm., 95 (1993) 135-141.
Pinto JF, Buckton G, Newton JM. The influence of four selected processing and formulation factors on the production of spheres by extrusion and spheronisation. Int J Pharm 1992; 83: 187-196.
Krogars K, Heinamaki J, Vesalahti J, Marvola M, Antikainen O, Yliruusi J. Extrusion-spheronization of pH-sensitive polymeric matrix pellete for possible colonic drug delivery. Int J Pharm 2000; 199: 187-194.
Lau CLS, Yu Q, Lister VY, Rough SL, Wilson DI, Zhang M. 2014. The evaluation of pellet size and shape during spheronisation of an extruded microcrystalline cellulose paste. Chem Eng Res Des. 92:2413–2424.
Newton JM, Chapman SR, Rowe RC. 1995a. The assessment of the scale-up performance of the extrusion/spheronisation process. Int J Pharma. 120: 95–99.
Thommes M, Kleinebudde P. 2007. Properties of pellets manufactured by wet extrusion/spheronization process using kappa-carrageenan: effect of process parameters. AAPS PharmSciTech. 8: E95.
Rahman NU, Yuen KH. Eudragit NE40-Drug Mixed Coating System for Controlling Drug Release of Core Pellets. Drug Dev Ind Pharm 2005;31:339-47.
Mehta KA, Kislalioglu MS, Phuapradit W, Malick AW, Shah NH. Effect of formulation and process variables on porosity parameters and release rates from a multiunit erosion matrix of a poorly soluble drug. J Control Release 2000;63:201-11.
R. W. Korsmeyer, R. Gurny, E. Doelker, P. Buri and N. A. Peppas, Mechanisms of solute release from porous hydrophilic polymers, Int. J. Pharm. 15 (1983) 25–35; DOI: 10.1016/0378-5173(83) 90064-9.
Di Pretoro G., Zema, L., Gazzaniga, A., Rough, S.L., Wilson, D.I., 2010. Extrusion-spheronisation of highly loaded 5-ASA multiparticulate dosage forms. International Journal of Pharmaceutics 402, 153–164.
